MD, The University of Texas Southwestern Medical School; PhD, The University of Texas at Austin
Internal Medicine - East Tennessee State University; Neurology - Mount Sinai Icahn School of Medicine
I earned my PhD in neuroscience before choosing to pursue an MD. Having a pre-existing interest in neurology at the start of medical school, I quickly became drawn to neuro-oncology. As a scientist, I recognize how much these patients can stand to benefit from bench to bedside research. I am now a board-certified neurologist who has completed my adult neuro-oncology fellowship and am qualified to care for people with a wide range of primary and metastatic brain tumors as well as the neurologic side effects of systemic cancers and their treatments.
Additionally, my clinical and research interests for the past ten years have focused on neurofibromatosis type 1 (NF1), which is a genetic tumor-predisposition syndrome associated with the growth of benign neurofibromas along the peripheral nerves. People with this condition are at higher risk for several different cancer types and of some benign tumors becoming cancerous. My laboratory research is working to identify the factors that lead a benign neurofibroma to develop into a malignant sarcoma in NF1. By identifying the mechanism and the cell type that underlies this transition, I hope to one day identify therapies to prevent it.
Personally, my hobbies include painting, cooking, and writing. I previously volunteered as a foster home for abandoned and abused dogs and cats. I live in Manhattan with my family and our elderly long-haired dachshund. Currently, my career is focused on laboratory research, however, I also occasionally work as part of the Neurology Service’s inpatient and consult teams.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Rebecca Brown discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].